跳至主要内容
临床试验/NCT02298244
NCT02298244Unknown不适用

Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary Hypertension

Krasnoyarsk Regional Hospital0 个研究点目标入组 20 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
主要终点
Perioperative Complications

研究概览

简要总结

Some patients with a long history of AF develops PH "reactive" type with an increase in pulmonary vascular resistance due to vasoconstriction or structural changes of the vascular wall. RFA PVI + RFA GP is the "gold standard" in the treatment of patients with persistent AF, do not respond to optimal therapy. The rear area of the pulmonary artery bifurcation is adjacent to the roof and part of the front of the left atrium. In the projection of this area are ganglionic plexus of the left atrium, the sympathetic nerve fibers of the pulmonary artery and baroreceptors main pulmonary artery.Recent studies have shown that radiofrequency denervation of the pulmonary artery improves the quality of life in patients with PH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients with symptomatic, drug - refractory AF ( inefficiency 1C or III Class antiarrhythmic drugs), history of AF 6 months or more without the restoration of sinus rhythm.
  • •MPAP ≥25 mmHg
  • •PCWP≥15 mmHg
  • •Pulmonary vascular resistance (PVR). The PVR =(mPAP-PCWP)/ carbon monoxide] > 2.5 woods unit

排除标准

  • •Left ventricular ejection fraction <35%
  • •Diameter LA> 60 mm on transthoracic echocardiography in the "M" -Mode or volume of LA more than 140 ml
  • •Significant regurgitation at the mitral valve
  • •Uncorrected congenital heart disease
  • •RFA PVI, RFA GP, PADN in history
  • •Foregoing heart surgery
  • •Life expectancy less than 12 months
  • •WHO group I, III, IV, V pulmonary artery hypertension
  • •Tricuspid valve stenosis, pulmonary supravalve stenosis.
  • •Pregnancy
  • •Thromboembolism LA history
  • •Hyperthyroidism.

研究组 & 干预措施

PV isolation + GP Ablation

Active Comparator

干预措施: PV isolation + GP Ablation (Procedure)

PV isolation + GP ablation + Pulmonary GP ablation

Active Comparator

干预措施: PV isolation + GP ablation + Pulmonary GP ablation (Procedure)

结局指标

主要结局

Perioperative Complications

时间窗: 6 months

perforation / dissection at any level, an acute thrombosis in the pulmonary artery, re - hospitalization due to Pulmonary Hypertension, Atrial Fibrillation) immediately after and at 1, 3, 6 months after procedure

death

时间窗: 6 months

all-cause death at 1, 3, 6 months after procedure

次要结局

  • recurrence of AF / AFL / AT(6 months)
  • Quality of life(6 months)
  • Mean Pulmonary Artery Pressure(6 months)
  • 6-minute walk distance(6 months)
  • Pulmonary vascular resistance(1 month)
  • Assessment of respiratory function(6 months)

研究者

发起方
Krasnoyarsk Regional Hospital
申办方类型
Other
责任方
Sponsor

相似试验